ACG
LLY icon

Allen Capital Group’s Eli Lilly LLY Stock Holding History

Allen Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
1,918
+16
+0.8% +$16.2K 0.16% 103
2025
Q4 		$2.04M Buy
1,902
+461
+32% +$441K 0.19% 97
2025
Q3 		$1.1M Sell
1,441
-383
-21% -$285K 0.1% 123
2025
Q2 		$1.42M Buy
1,824
+254
+16% +$197K 0.15% 101
2025
Q1 		$1.3M Buy
1,570
+170
+12% +$141K 0.15% 101
2024
Q4 		$1.08M Buy
1,400
+536
+62% +$444K 0.13% 107
2024
Q3 		$765K Buy
864
+176
+26% +$158K 0.09% 120
2024
Q2 		$623K Buy
688
+117
+20% +$93.6K 0.09% 122
2024
Q1 		$444K Buy
571
+134
+31% +$95.4K 0.06% 137
2023
Q4 		$255K Buy
+437
New +$255K 0.04% 155
2022
Q1 		– Sell
-810
Closed -$224K – 177
2021
Q4 		$224K Buy
+810
New +$205K 0.04% 150

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Allen Capital Group's LLY Position: Q1 2026 in Review

Allen Capital Group increased its Eli Lilly (LLY) stake by 0.84% in Q1 2026, buying an estimated $16.2K and bringing the position to 1,918 shares worth $1.76M. The position accounts for 0.16% of the portfolio, ranked #103.

Allen Capital Group first reported a position in LLY in Q4 2021 and has held it in 11 quarters since. The position peaked at $2.04M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allen Capital Group held 1,918 shares of Eli Lilly worth $1.76M as of Q1 2026.
  • Allen Capital Group bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.16% of Allen Capital Group's portfolio in Q1 2026, its #103 holding.
  • Allen Capital Group first reported a position in Eli Lilly in Q4 2021 and has held it in 11 quarters since.
  • Allen Capital Group's Eli Lilly position peaked at $2.04M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allen Capital Group's 13F filing for Q1 2026, filed 27 May 2026.